The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CASPAR (Alliance A031902): A randomized, phase III trial of enzalutamide (ENZ) with rucaparib (RUCA)/placebo (PBO) as a novel therapy in first-line metastatic castration-resistant prostate cancer (mCRPC).
 
Arpit Rao
Honoraria - Bayer; Lilly; Sanofi
Consulting or Advisory Role - Lilly (Inst)
Research Funding - Clovis Oncology (Inst); Lilly (Inst); Pfizer/Astellas (Inst); Seattle Genetics/Astellas (Inst)
 
Charles J. Ryan
Honoraria - Bayer; Janssen Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Clovis Oncology (Inst); Dendreon; Myovant Sciences; Roivant
Research Funding - Clovis Oncology (Inst); Genzyme (Inst)
 
David James VanderWeele
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca (Inst); Department of Defense-Prostate Cancer Research Program; Fortis (Inst); Prostate Cancer Foundation
Travel, Accommodations, Expenses - Genzyme
 
Glenn Heller
Research Funding - Janssen Diagnostics
 
Lionel D Lewis
Consulting or Advisory Role - 7 Hills Pharma; G1 Therapeutics
Research Funding - AstraZeneca; Bristol-Myers Squibb; Novartis
Expert Testimony - Amgen
 
Colleen Watt
No Relationships to Disclose
 
Ronald C. Chen
Consulting or Advisory Role - Abbvie; Accuray; Accuray; Bayer; Blue Earth Diagnostics; Genentech; Medivation/Astellas; Myovant Sciences; Myovant Sciences; Pfizer
Research Funding - Accuray
 
Robert Grubb
Employment - Anthem Foundation (I)
Stock and Other Ownership Interests - Anthem (I)
Research Funding - FKD Therapies; GlaxoSmithKline
 
Olwen Mary Hahn
Leadership - Via Oncology
Stock and Other Ownership Interests - Teleflex Medical; Teleflex Medical
Honoraria - Cardinal Health (I)
Consulting or Advisory Role - Pfizer; Pfizer
Travel, Accommodations, Expenses - Cardinal Health (I)
 
Himisha Beltran
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Genzyme; GlaxoSmithKline; Janssen Oncology; Pfizer
Research Funding - Abbvie/Stemcentrx (Inst); Janssen (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Curium Pharma; Curium Pharma; Endocyte; Johnson & Johnson; ORIC Pharmaceuticals
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Endocyte; Fujifilm